Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis
Personlig udvikling
"Tom Abate's reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner." ―Thom Calandra, editor in chief, CBS MarketWatch
In The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry.
Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for
• tracking the effect of breaking news and the NASDAQ
• anticipating drug trial announcements and FDA approvals
• assessing the potential market, patent rights, and distribution deals for a drug
He looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.
© 2025 Times Books (E-bog): 9781466851214
Udgivelsesdato
E-bog: 16. oktober 2025
Over 600.000 titler
Download og nyd titler offline
Eksklusive titler + Mofibo Originals
Børnevenligt miljø (Kids Mode)
Det er nemt at opsige når som helst
For dig som lytter og læser ofte.
1 konto
100 timer/måned
Eksklusivt indhold hver uge
Fri lytning til podcasts
Ingen binding
For dig som lytter og læser ubegrænset.
1 konto
Ubegrænset adgang
Eksklusivt indhold hver uge
Fri lytning til podcasts
Ingen binding
For dig som ønsker at dele historier med familien.
2-6 konti
100 timer/måned pr. konto
Fri lytning til podcasts
Kun 39 kr. pr. ekstra konto
Ingen binding
2 konti
179 kr. /månedFor dig som vil prøve Mofibo.
1 konto
20 timer/måned
Gem op til 100 ubrugte timer
Eksklusivt indhold hver uge
Fri lytning til podcasts
Ingen binding
Dansk
Danmark
